119 related articles for article (PubMed ID: 23179584)
1. Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis.
Eiró N; Ovies C; Fernandez-Garcia B; Álvarez-Cuesta CC; González L; González LO; Vizoso FJ
Arch Dermatol Res; 2013 Jan; 305(1):59-67. PubMed ID: 23179584
[TBL] [Abstract][Full Text] [Related]
2. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.
González-Reyes S; Marín L; González L; González LO; del Casar JM; Lamelas ML; González-Quintana JM; Vizoso FJ
BMC Cancer; 2010 Dec; 10():665. PubMed ID: 21129170
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients.
Tittarelli A; González FE; Pereda C; Mora G; Muñoz L; Saffie C; García T; Díaz D; Falcón C; Hermoso M; López MN; Salazar-Onfray F
Cancer Immunol Immunother; 2012 Nov; 61(11):2067-77. PubMed ID: 22552381
[TBL] [Abstract][Full Text] [Related]
4. Increased nucleic Acid receptor expression in chronic periodontitis.
Sahingur SE; Xia XJ; Voth SC; Yeudall WA; Gunsolley JC
J Periodontol; 2013 Oct; 84(10):e48-57. PubMed ID: 23646855
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of TLR3 and TLR4 in keratocystic odontogenic tumor (KCOT): A comparative immunohistochemical study in primary, recurrent, and nevoid basal cell carcinoma syndrome (NBCCS)--associated lesions.
Leonardi R; Perrotta RE; Crimi S; Matthews JB; Barbato E; dos Santos JN; Rusu M; Bufo P; Bucci P; Pannone G
J Craniomaxillofac Surg; 2015 Jul; 43(6):733-7. PubMed ID: 25976039
[TBL] [Abstract][Full Text] [Related]
6. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
Naffouje S; Naffouje R; Bhagwandin S; Salti GI
Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis.
Beklen A; Hukkanen M; Richardson R; Konttinen YT
Oral Microbiol Immunol; 2008 Oct; 23(5):425-31. PubMed ID: 18793367
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
9. Recurrent aphthous ulcers--a Toll-like receptor-mediated disease?
Hietanen J; Häyrinen-Immonen R; Al-Samadi A; Trokovic N; Koskenpato K; Konttinen YT
J Oral Pathol Med; 2012 Feb; 41(2):158-64. PubMed ID: 21899597
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.
Sheyhidin I; Nabi G; Hasim A; Zhang RP; Ainiwaer J; Ma H; Wang H
World J Gastroenterol; 2011 Aug; 17(32):3745-51. PubMed ID: 21990957
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of toll-like receptor 3, 4, and 9 in gastric cancer.
Fernandez-Garcia B; Eiró N; González-Reyes S; González L; Aguirre A; González LO; Del Casar JM; García-Muñiz JL; Vizoso FJ
J Immunother; 2014; 37(2):77-83. PubMed ID: 24509170
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Toll-like receptors in chronic hyperplastic candidosis.
Ali A; Natah S; Konttinen Y
Oral Microbiol Immunol; 2008 Aug; 23(4):299-307. PubMed ID: 18582329
[TBL] [Abstract][Full Text] [Related]
13. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation.
Månsson A; Adner M; Höckerfelt U; Cardell LO
Immunology; 2006 Aug; 118(4):539-48. PubMed ID: 16780564
[TBL] [Abstract][Full Text] [Related]
14. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of B-cell density in cutaneous melanoma.
Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of β2-adrenergic receptor expression in malignant melanoma.
Shimizu A; Kaira K; Mori K; Kato M; Shimizu K; Yasuda M; Takahashi A; Oyama T; Asao T; Ishikawa O
Tumour Biol; 2016 May; 37(5):5971-8. PubMed ID: 26596834
[TBL] [Abstract][Full Text] [Related]
18. Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients.
Donizy P; Kaczorowski M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Anticancer Res; 2015 Jan; 35(1):351-8. PubMed ID: 25550571
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor expression in the human nasopharyngeal tonsil (adenoid) and palantine tonsils: a preliminary report.
Lesmeister MJ; Bothwell MR; Misfeldt ML
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):987-92. PubMed ID: 16325925
[TBL] [Abstract][Full Text] [Related]
20. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
